Literature DB >> 9448739

Co-purification of microsomal epoxide hydrolase with the warfarin-sensitive vitamin K1 oxide reductase of the vitamin K cycle.

T M Guenthner1, D Cai, R Wallin.   

Abstract

Vitamin K1 oxide reductase activity has been partially purified from rat liver microsomes. A three-step procedure produced a preparation in which warfarin-sensitive vitamin K1 oxide reductase activity was 118-fold enriched over the activity in intact rat liver microsomes. A major component of the multi-protein mixture was identified as a 50 kDa protein that strongly cross-reacts with antiserum prepared against homogeneous rat liver microsomal epoxide hydrolase. The reductase preparation also had a high level or epoxide hydrolase activity against two xenobiotic epoxide substrates. The K(m) values for hydrolysis by the reductase preparation were similar to those for homogeneous microsomal epoxide hydrolase itself, and the specific hydrolase activities of the reductase preparation were 25-35% of the specific activities measured for the homogeneous hydrolase preparation. Antibodies prepared against homogeneous microsomal epoxide hydrolase inhibited up to 80% of reductase activity of the reductase preparation. Homogeneous microsomal epoxide hydrolase had no vitamin K1 oxide reductase activity. This evidence suggests that microsomal epoxide hydrolase, or a protein that is very similar to it, is a major functional component of a multi-protein complex that is responsible for vitamin K1 oxide reduction in rat liver microsomes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9448739     DOI: 10.1016/s0006-2952(97)00431-0

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  7 in total

1.  Monoclonal antibodies reveal multiple forms of expression of human microsomal epoxide hydrolase.

Authors:  Hongying Duan; Akira Takagi; Hidekazu Kayano; Isamu Koyama; Christophe Morisseau; Bruce D Hammock; Toshitaka Akatsuka
Journal:  Toxicol Appl Pharmacol       Date:  2012-01-28       Impact factor: 4.219

2.  A novel activity of microsomal epoxide hydrolase: metabolism of the endocannabinoid 2-arachidonoylglycerol.

Authors:  Kasem Nithipatikom; Michael P Endsley; Adam W Pfeiffer; John R Falck; William B Campbell
Journal:  J Lipid Res       Date:  2014-06-23       Impact factor: 5.922

3.  Functional analysis of human microsomal epoxide hydrolase genetic variants.

Authors:  Vinayak P Hosagrahara; Allan E Rettie; Christopher Hassett; Curtis J Omiecinski
Journal:  Chem Biol Interact       Date:  2004-11-20       Impact factor: 5.192

4.  Is there a role for MDR1, EPHX1 and protein Z gene variants in modulation of warfarin dosage? a study on a cohort of the Egyptian population.

Authors:  Marianne Samir Makboul Issac; Maggie S El-Nahid; Marian Youssry Wissa
Journal:  Mol Diagn Ther       Date:  2014-02       Impact factor: 4.074

5.  Alternative promoters determine tissue-specific expression profiles of the human microsomal epoxide hydrolase gene (EPHX1).

Authors:  Shun-Hsin Liang; Christopher Hassett; Curtis J Omiecinski
Journal:  Mol Pharmacol       Date:  2004-10-01       Impact factor: 4.436

6.  Expression of a novel mRNA transcript for human microsomal epoxide hydrolase (EPHX1) is regulated by short open reading frames within its 5'-untranslated region.

Authors:  Hong Loan Nguyen; Xi Yang; Curtis J Omiecinski
Journal:  RNA       Date:  2013-04-05       Impact factor: 4.942

Review 7.  Structural and functional insights into enzymes of the vitamin K cycle.

Authors:  J-K Tie; D W Stafford
Journal:  J Thromb Haemost       Date:  2016-01-29       Impact factor: 5.824

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.